# This Study Evaluates the Impact of the Sodium Management Tool (SMT) on Hemodialysis Patient Outcomes Compared to Standard Care

> **NCT06896786** · NA · NOT_YET_RECRUITING · sponsor: **Sharon-Rose Maloney** · enrollment: 30 (estimated)

## Conditions studied

- Hemodialysis
- Interdialytic Weight Gain
- Intradialytic Hypotension

## Interventions

- **OTHER:** dialysis assisted with the sodium management tool

## Key facts

- **NCT ID:** NCT06896786
- **Lead sponsor:** Sharon-Rose Maloney
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06896786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06896786, "This Study Evaluates the Impact of the Sodium Management Tool (SMT) on Hemodialysis Patient Outcomes Compared to Standard Care". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT06896786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*